These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6499908)
1. Beneficial effect of cyclosporin A on the lymphocytic choriomeningitis virus infection in mice. Saron MF; Shidani B; Guillon JC; Truffa-Bachi P Eur J Immunol; 1984 Nov; 14(11):1064-6. PubMed ID: 6499908 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Battegay M; Kyburz D; Hengartner H; Zinkernagel RM Eur J Immunol; 1993 Dec; 23(12):3236-41. PubMed ID: 8258339 [TBL] [Abstract][Full Text] [Related]
3. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Thomsen AR; Volkert M; Marker O Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926 [TBL] [Abstract][Full Text] [Related]
4. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection. Moskophidis D; Lehmann-Grube F J Immunol; 1984 Dec; 133(6):3366-70. PubMed ID: 6092472 [TBL] [Abstract][Full Text] [Related]
5. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081 [TBL] [Abstract][Full Text] [Related]
7. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody. Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992 [TBL] [Abstract][Full Text] [Related]
8. Infection of Syrian hamsters with lymphocytic choriomeningitis virus: comparison of detection methods. Thacker WL; Lewis VJ; Shaddock JH; Winkler WG Am J Vet Res; 1982 Aug; 43(8):1500-2. PubMed ID: 7049024 [TBL] [Abstract][Full Text] [Related]
9. Change in susceptibility of C3H-HeJ mice to LCM virus infection. Oldstone MB; Dixon FJ J Immunol; 1973 Nov; 111(5):1613-5. PubMed ID: 4583080 [No Abstract] [Full Text] [Related]
10. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. Eschli B; Zellweger RM; Wepf A; Lang KS; Quirin K; Weber J; Zinkernagel RM; Hengartner H J Virol; 2007 Nov; 81(21):11650-7. PubMed ID: 17699567 [TBL] [Abstract][Full Text] [Related]
11. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. Doherty PC; Zinkernagel RM; Ramshaw IA J Immunol; 1974 Apr; 112(4):1548-52. PubMed ID: 4592605 [No Abstract] [Full Text] [Related]
12. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. Lehmann-Grube F; Assmann U; Löliger C; Moskophidis D; Löhler J J Immunol; 1985 Jan; 134(1):608-15. PubMed ID: 3871115 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925 [TBL] [Abstract][Full Text] [Related]
15. MHC and non-MHC genes regulate elimination of lymphocytic choriomeningitis virus and antiviral cytotoxic T lymphocyte and delayed-type hypersensitivity mediating T lymphocyte activity in parallel. Thomsen AR; Marker O J Immunol; 1989 Feb; 142(4):1333-41. PubMed ID: 2783710 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Wille A; Gessner A; Lother H; Lehmann-Grube F Eur J Immunol; 1989 Jul; 19(7):1283-8. PubMed ID: 2503388 [TBL] [Abstract][Full Text] [Related]
17. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. Johnson ED; Cole GA J Exp Med; 1975 Apr; 141(4):866-81. PubMed ID: 47887 [TBL] [Abstract][Full Text] [Related]
19. Course of lymphocytic choriomeningitis virus infection in young and aged mice. Anderlik P; Szeri I; Bános S; Radnai B Acta Microbiol Acad Sci Hung; 1975; 22(1):27-31. PubMed ID: 1111261 [TBL] [Abstract][Full Text] [Related]
20. Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Cole GA; Gilden DH; Monjan AA; Nathanson N Fed Proc; 1971; 30(6):1831-41. PubMed ID: 4942053 [No Abstract] [Full Text] [Related] [Next] [New Search]